The first batch of imported covid-19 oral drugs arrived at the front line of anti epidemic today

General technology China Meheco Group Co.Ltd(600056) and Pfizer’s covid-19 virus treatment drug paxlovid will be delivered to Changchun City, Jilin Province today for the first line of anti epidemic. PAXLOVID is a Pfizer Inc oral small molecule COVID-19 virus therapeutic agent for the treatment of mild to moderate New Coronavirus pneumonia (COVID-19) in adults with severe risk factors. In March 9th, general technology China Meheco Group Co.Ltd(600056) signed an agreement with Pfizer Inc to take charge of PAXLOVID’s commercial operation in the Chinese mainland market.